AMEX:AEON (USA)
Â
Ordinary Shares - Class A
$
0.66
+0.060 (+10.07%)
07:08 PM EST
What is a stock summary page? Click here for an overview.
Business Description
AEON Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US00791X1000
Share Class Description:
AEON: Ordinary Shares - Class ADescription
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -8.01 | |||||
Debt-to-Equity | -0.51 | |||||
Debt-to-EBITDA | -0.75 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 33.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.05 | |||||
9-Day RSI | 21.99 | |||||
14-Day RSI | 23.65 | |||||
3-1 Month Momentum % | -80.86 | |||||
6-1 Month Momentum % | -82.68 | |||||
12-1 Month Momentum % | -99.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.22 | |||||
Quick Ratio | 0.22 | |||||
Cash Ratio | 0.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.8 | |||||
Shareholder Yield % | 7718.57 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 536.11 | |||||
ROIC % | -735.14 | |||||
ROC (Joel Greenblatt) % | -2185.97 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 0.01 | |||||
Forward PE Ratio | 0.02 | |||||
EV-to-EBIT | -0.75 | |||||
EV-to-Forward-EBIT | -3.26 | |||||
EV-to-EBITDA | -0.75 | |||||
EV-to-FCF | -0.85 | |||||
Earnings Yield (Greenblatt) % | -133.33 | |||||
FCF Yield % | -2679.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:AEON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AEON Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 58.32 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 156.96 | ||
14-Day RSI | 23.65 | ||
14-Day ATR ($) | 0.974275 | ||
20-Day SMA ($) | 3.0505 | ||
12-1 Month Momentum % | -99.11 | ||
52-Week Range ($) | 0.4 - 1236.239999 | ||
Shares Outstanding (Mil) | 1.11 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AEON Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AEON Biopharma Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
AEON Biopharma Inc Frequently Asked Questions
What is AEON Biopharma Inc(AEON)'s stock price today?
The current price of AEON is $0.66. The 52 week high of AEON is $1236.24 and 52 week low is $0.40.
When is next earnings date of AEON Biopharma Inc(AEON)?
The next earnings date of AEON Biopharma Inc(AEON) is 2025-05-09 Est..
Does AEON Biopharma Inc(AEON) pay dividends? If so, how much?
AEON Biopharma Inc(AEON) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |